- Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York Times
- Novo Nordisk Shares Plummet as Competition Weighs on Sales The Wall Street Journal
- Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance CNBC
- Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding NPR
- Wegovy maker Novo’s profit warning triggers $70 billion share rout Reuters
Source link
